Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BI 836880
i
Other names:
BI 836880, BI-836880, VEGF/Ang2, anti-VEGF/Ang2 Nanobody, bi-specific Anti-VEGF/Ang2 Nanobody, BI836880
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Boehringer Ingelheim
Drug class:
VEGF inhibitor, Angiopoietin 2 inhibitor
Related drugs:
‹
recombinant human endostatin (5)
ivonescimab (3)
CU06 (0)
autologous activated lymphocytes (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
STAR-LLD SC (0)
ABT-510 (0)
AMG 386 (1)
CVX-241 (0)
L1-10 (0)
MEDI-3617 (0)
LY3127804 (0)
recombinant human endostatin (5)
ivonescimab (3)
CU06 (0)
autologous activated lymphocytes (0)
TAVO412 (0)
ZGGS18 (0)
PTC299 (0)
STAR-LLD SC (0)
ABT-510 (0)
AMG 386 (1)
CVX-241 (0)
L1-10 (0)
MEDI-3617 (0)
LY3127804 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login